Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Boehringer signs deal to develop cystic fibrosis gene therapy
Americas
Boehringer Ingelheim has teamed up with academic institutions and research companies in the UK to develop a long-term gene therapy for cystic fibrosis, according to a statement released on Monday, August 6.   9 August 2018
Europe
Emma Walmsley was selected in the LSIPR 50 2018 publication for​ ​her influence on the life sciences industry. She featured in the business and innovation section, as LSIPR reports.   9 August 2018
Broad Institute and DowDuPont grant CRISPR agriculture licence
Americas
The Broad Institute of MIT and Harvard and Corteva Agriscience, the agricultural division of DowDuPont, have jointly agreed to license CRISPR/Cas9 technology to the J R Simplot Company.   8 August 2018
Americas
Guy Birkenmeier, previously a partner in Baker McKenzie’s IP practice group, has joined Foley Gardere as a partner in the firm’s technology transactions and outsourcing practice.   8 August 2018
Europe
Antoine Petit was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.   8 August 2018
Americas
If enacted by Congress, the proposed amendment to the Hatch-Waxman Act would spell trouble for generic pharmaceutical companies seeking to take on brand competitors in patent litigation, says Janine Carlan of Arent Fox.   8 August 2018
Americas
Richard Gonzalez was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.   7 August 2018
Americas
Two Chinese nationals have been charged with conspiracy to steal rice technology from a US-based biotechnology company.   7 August 2018
Americas
Tony Coles was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.   6 August 2018
Americas
Spain-based pharmaceutical company Almirall will acquire Allergan’s dermatology portfolio.   6 August 2018